Entrada Therapeutics Inc

Symbol: TRDA
ISIN: US29384C1080

Price history of Entrada Therapeutics Inc

Loading price chart…

Overview

The stock exchange where this stock is listed, such as NASDAQ, NYSE or LSE. Exchange: NASDAQ
International Securities Identification Number: a globally unique 12-character code identifying this security. ISIN: US29384C1080
The ticker symbol used to trade this stock on the exchange, e.g. AAPL for Apple. Symbol: TRDA
The economic sector the company operates in, e.g. Technology or Financials. Sector: Healthcare
The specific industry within the sector, e.g. Consumer Electronics. Industry: Biotechnology
The currency in which the stock price is denominated. Currency: USD
Total market value of all outstanding shares: price × shares outstanding. Market Cap: 294.75M

Financial Ratios

Measure of the stock's volatility relative to the market. Beta > 1 means more volatile than the index. Beta: -0.26
Percentage revenue growth compared to the previous fiscal year. Revenue Growth: 63.38%
Earnings Per Share: net profit divided by the total number of outstanding shares. Earnings Per Share: -3.96
Net Margin: the percentage of revenue remaining as net profit after all costs and taxes. Net Margin: 0%
Debt Ratio: ratio of total debt to equity. Indicates how much of the company is financed by debt. Debt Ratio: 28.05%
Return on Equity: net income as a percentage of shareholders' equity. Measures how efficiently the company generates returns. Return on Equity: -54.1%
Dividend Yield: annual dividend payment as a percentage of the current stock price. Dividend Yield: 0%
Price-to-Book Ratio: market value divided by book value per share. P/B Ratio: 1.27

ESG Risk Ratings

i

ESG Risk Ratings measure how well a company manages environmental, social and governance factors. A lower risk score means less risk for investors.

ESG score36%

ESG Data 2022

ESG Risk Score:64.12
Grade:C+ C+
Performance Score:36%

ESG Rating Scale

A+AA-B+BB-C+CC-D+DD-